ESR1 and breast carcinoma: The above data of ERβ expression in normal mammary glands as well as the inhibitory effects observed with its activation in the absence of ERα and the suppression of the TGFβ pathway that it mediates argue for a negative effect of ERβ for EMT and a tumor-suppressor and anti-metastatic role in breast cancer.